Mei Han
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
57
Citations
2,297
Est. group size
—
Recurring co-author estimate
Active years
23
Publishing since 2003
Mei Han's research focuses on molecular mechanisms underlying cancer, vascular disease, and liver conditions, including how cells change identity or behavior (such as smooth muscle cells switching phenotypes, or liver cells undergoing epithelial-to-mesenchymal transition). Work spans topics like tumor metabolism, inflammation, atherosclerosis, and gene regulation, often using cell and animal models along with sequencing techniques. The publication record includes studies on specific proteins and pathways implicated in cancers (gastric, colorectal, liver, skin) and cardiovascular/inflammatory conditions.
Publication output rose to a peak around 2018-2019, then gradually declined and has remained at a lower, relatively steady level (averaging about 3-4 papers per year) over the past five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PKM2 crotonylation reprograms glycolysis in VSMCs, contributing to phenotypic switching
Oncogene · 2025
- Targeting ETHE1 inhibits tumorigenesis <i>in vitro</i> and <i>in vivo</i> by preventing aerobic glycolysis in gastric adenocarcinoma cells
Oncology Letters · 2025
- Smooth Muscle Silent Information Regulator 1 Contributes to Colitis in Mice
International Journal of Molecular Sciences · 2025
- GJA4 expressed on cancer associated fibroblasts (CAFs)—A ‘promoter’ of the mesenchymal phenotype
Translational Oncology · 2024
- Reciprocal Inhibitory Regulation of TGF-β1 Signaling and Cholesterol Metabolism in Hepatocytes
Zeitschrift für Gastroenterologie · 2024
- WIND-RESISTANT AND SEISMIC DESIGN OF THIRD GENERATION NUCLEAR POWER ENGINEERING VNA SYSTEMS
2024
- The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation
Cellular and Molecular Gastroenterology and Hepatology · 2023
- The interplay of TGF-β1 and cholesterol orchestrating hepatocyte cell fate, EMT, and signals for HSC activation
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Single-cell RNA sequencing reveals aortic cellular heterogeneity in MSC_ITGB3-treated ApoE-/- mice on a high-fat diet
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- DCBLD1 modulates angiogenesis by regulating of the VEGFR-2 endocytosis in endothelial cells
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Signal Transduction and Targeted Therapy · 2022
- An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment
DOAJ (DOAJ: Directory of Open Access Journals) · 2022
- USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
Journal of Inflammation Research · 2022
- Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger points via TNF-α/ NF-κB signaling pathway in rats
Frontiers in Pharmacology · 2022
- An analysis of the significance of the Tre2/Bub2/CDC 16 (TBC) domain protein family 8 in colorectal cancer
Scientific Reports · 2022
- Zeitschrift für Gastroenterologie×4
- Molecular Medicine Reports×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Biomedicine & Pharmacotherapy×2
- Cell Death and Disease×2
- Yang Yang
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Alberto Ortega
Biochemistry, Genetics and Molecular Biology · Indiana University
- Sarah McGovern
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Alexander J. Fitt
Biochemistry, Genetics and Molecular Biology · Indiana University
- Kenneth P. Nephew
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile